PATISIRAN for Polyneuropathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 36 adverse event reports in the FDA FAERS database where PATISIRAN was used for Polyneuropathy.
Most Reported Side Effects for PATISIRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 250 | 9.2% | 250 | 33 |
| Product dose omission issue | 175 | 6.5% | 11 | 113 |
| Fatigue | 165 | 6.1% | 3 | 46 |
| Infusion related reaction | 134 | 5.0% | 0 | 29 |
| Hospitalisation | 127 | 4.7% | 8 | 127 |
| Asthenia | 108 | 4.0% | 8 | 48 |
| Fall | 107 | 4.0% | 3 | 65 |
| Intentional dose omission | 107 | 4.0% | 6 | 65 |
| Cardiac failure | 95 | 3.5% | 26 | 65 |
| Dyspnoea | 87 | 3.2% | 10 | 54 |
| Malaise | 82 | 3.0% | 6 | 35 |
| Inappropriate schedule of product administration | 80 | 3.0% | 5 | 49 |
| Diarrhoea | 78 | 2.9% | 2 | 31 |
| Nausea | 78 | 2.9% | 3 | 35 |
| Therapy interrupted | 73 | 2.7% | 5 | 57 |
Other Indications for PATISIRAN
Hereditary neuropathic amyloidosis (1,849)
Product used for unknown indication (569)
Amyloidosis (111)
Amyloidosis senile (91)
Cardiac amyloidosis (56)
Acquired attr amyloidosis (17)
Cardiomyopathy (7)
Familial amyloidosis (7)
Other Drugs Used for Polyneuropathy
PREGABALIN (884)
HUMAN IMMUNOGLOBULIN G (529)
GABAPENTIN (180)
INOTERSEN (62)
RITUXIMAB (56)
DULOXETINE (45)
LENALIDOMIDE (42)
EPLONTERSEN (21)
CLONAZEPAM (17)
METAMIZOLE (16)